Correlation Between Capillary Refill Time and Perfusion Index in Critically Ill Patients

Study acronym: CRIPI
StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Trial completed
    • Primary and study completion dates changed from estimate of Sep 28, 2026 to Sep 29, 2026
    • Eligibility criteria expanded, about 6 words
  2. Minor Enrollment closed, study ongoing
    • Primary and study completion moved earlier from May 29, 2027 to Sep 2026
    • Enrollment target: 250 to 267
    v4
  3. Minor Trial status: Recruiting to Active, Not Recruiting
    • Primary and study completion dates: May 29, 2027 to Sep 2026
    • Site details revised at 2 of 2 sites
    v3
  4. Notable Recruitment opened
    • Primary and study completion dates: Jun 2027 to May 29, 2027
    • Start date changed from estimate of May 2026 to Apr 29, 2026
    • Site details revised at 2 of 2 sites
    v2
  5. Minor Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Assessment of capillary refill time (CRT) is a cornerstone of tissue perfusion monitoring in critically ill patients. CRT measurement is performed by applying brief and gentle pressure (for a few seconds) to a small area of skin until blanching occurs. CRT is defined as the time, in seconds, required for the skin surface to return to its initial color after release of pressure. Although CRT is a monitoring tool used on a daily basis in emergency departments and critical care units, its practical measurement modalities remain poorly standardized and time-consuming. Consequently, there is no consensus regarding the most reproducible bedside method for CRT assessment. Moreover, repeated CRT measurements during patient management are resource-intensive in terms of medical time and may raise issues related to healthcare staff availability. The perfusion index (PI) is a marker of tissue perfusion derived from a pulse oximetry sensor. This monitoring device is routinely used in all critically ill patients. It is placed on the finger and worn continuously, including during patient transport. Because PI measurement is automatic and continuous, establishing its correlation with CRT could allow for more precise tissue perfusion monitoring while reducing the time burden associated with bedside assessments in critically ill patients.
Trial Details
NCT Number NCT07555041
Lead Sponsor Hospices Civils de Lyon
Conditions
(from sponsor)
Shock State, Hemodynamics Instability, Microcirculation, Monitoring
Enrollment 267 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov